Related Experiment Video
Updated: Feb 19, 2026

Effect of Hyaluronic Acid 35 kDa on an In Vitro Model of Preterm Small Intestinal Injury and Healing Using Enteroid-Derived Monolayers
Published on: July 28, 2022
The initial prophylactic antibiotic usage and subsequent necrotizing enterocolitis in high-risk premature infants: a
Xue Fan1,2, Li Zhang1,2, Jun Tang3,4
1Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu, 610041, Sichuan, China.
Insights
Prophylactic antibiotic use in premature infants did not reduce the incidence of necrotizing enterocolitis (NEC). Prolonged antibiotic exposure showed a trend toward increased NEC risk, suggesting current practices should be re-evaluated.
Area of Science:
- Neonatalogy
- Pediatric Infectious Diseases
- Clinical Pharmacy
Background:
- Necrotizing enterocolitis (NEC) is a serious gastrointestinal condition affecting premature infants.
- Prophylactic antibiotic use is sometimes employed in high-risk neonates, but its efficacy in preventing NEC is debated.
Purpose of the Study:
- To evaluate the association between prophylactic antibiotic administration and the subsequent development of NEC in high-risk premature infants.
Main Methods:
- A comprehensive literature search was conducted across major databases (PubMed, EMBASE, CENTRAL, Web of Science).
- Nine studies involving 5207 infants were included in this meta-analysis.
Main Results:
- Overall prophylactic antibiotic use showed a non-significant trend towards increased NEC incidence (OR 0.75; 95% CI 0.26-2.17).
- Prolonged exposure to prophylactic antibiotics was significantly associated with an increased risk of NEC (OR 1.31; 95% CI 1.08-1.59) compared to limited use.
Conclusions:
- Existing evidence does not support the routine use of prophylactic antibiotics to prevent NEC in high-risk premature infants.
- The findings suggest that prolonged antibiotic exposure may even increase NEC risk.
Objective:
To investigate the correlation between the initial prophylactic antibiotic use and the subsequent NEC in high-risk premature infants.
Methods:
We performed a literature search of PubMed, EMBASE, the Cochrane Central Register of Controlled Trials (CENTRAL), and the Web of Science, and nine studies with a total of 5207 infants were selected for inclusion in this study.
Results:
The pooled estimate for the seven studies combined indicating that prophylactic antibiotic usage was associated with a non-significant trend toward increased incidence of NEC [odds ratio (OR) 0.75; 95% confidence interval (CI) 0.26-2.17], and prolonged exposure to prophylactic antibiotics, compared with limited prophylactic antibiotic use, was associated with a significant trend toward the risk of increasing incidence of NEC (OR 1.31; 95% CI 1.08-1.59).
Conclusion:
Current evidence does not support the use of prophylactic antibiotics to reduce the incidence of NEC for high-risk premature infants.
Related Concept Videos
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Acute Pyelonephritis II: Diagnostic Studies and Management
Pharmacokinetics in Pediatric Patients: Drug Excretion
Drug Dosing: Infants and Children

